Confronting America’s Smoking Pandemic, Part 2: 1967–1985

Slideshow

Dr. Alan Blum and Cancer Network have partnered to assemble a four-part slideshow series addressing the history of America’s smoking pandemic. Part 2 highlights the rise of tobacco awareness, and anti-smoking activism and legislation.

Confronting America’s Smoking PandemicPart 1: From Early Evidence to Global Battle, 1939–1966Part 2: An Era of Activism, 1967–1985Part 3: Regulation, Legislation, Litigation, 1986–1999Part 4: Failures and Successes 2000–2016

References:

1. Center for the Study of Tobacco and Society. Robert Kennedy speaks at the 1967 World Conference on Smoking and Health. Video. 1967. Published to YouTube on October 1, 2014.

2. American Cancer Society. History of the Great American Smokeout event.

3. US Department of Health and Human Services. Centers for Disease Control and Prevention (US). The health consequences of smoking-50 years of progress. A report of the Surgeon General. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health; 2014.

4. Berlyne D. Clearing the air: an overview of smoke-free air laws. RWJF Retrospective Series. Princeton, NJ: Robert Wood Johnson Foundation; April 2011.

5. US Legal, Inc. Smoking regulations in California.

6. SourceWatch. Doctors ought to care.

7. US Public Health Service. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. 4. Nicotine addiction: past and present.

8. US Department of Health Education and Welfare (DHEW), Public Health Service (PHS). Smoking and health: a report of the Surgeon General. DHEW publication no. (PHS) 79-50066. 1979.

9. American College of Chest Physicians. History of ACCP antitobacco activity. Updated June 2010.

10. Neuman MD, Bitton A, Glantz SA. Tobacco industry influence on the definition of tobacco related disorders by the American Tobacco Association. Tobacco Control. 2005;14:328-37.

11. National Library of Medicine. Profiles in Science. The C. Everett Koop Papers: tobacco, second-hand smoke, and the campaign for a smoke-free America.

12. National Cancer Institute. Division of Cancer Prevention Oral History Project: Interview with Peter Greenwald. Conducted on December 4, 2008, by Victoria Harden. Produced by History Associates Incorporated, Rockville, MD.

13. Death in the West. 1976. Film. Thames Television, UK.

14. National Institutes of Health, Centers for Disease Control and Prevention. Use of FDA-approved pharmacologic treatments for tobacco dependence-United States, 1984–1998. MMWR July 28, 2000.

15. US Department of Health and Human Services, US Food and Drug Administration. FDA approves novel medication for smoking cessation. FDA news release P06-67. May 11, 2006.

16. US Department of Health and Human Services. US Food and Drug Administration. FDA: Boxed warning on serious mental health events to be required for Chantix and Zyban. FDA news release. July 1, 2009.

Recent Videos
Patients with lung cancer who achieve a complete response with neoadjuvant therapy may not experience additional benefit with adjuvant immunotherapy.
Numerous trials have displayed the evolution of EGFR inhibition alone or with chemotherapy/radiation in the EGFR-mutated lung cancer space.
2 experts are featured in this series.
Although high grade adverse effects are infrequent among patients undergoing treatment for SCLC, CRS and ICANS may occur in higher frequencies.
Two experts are featured in this series.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
4 experts are featured in this series.
Based on a patient’s SCLC subtype, and Schlafen 11 status, patients will be randomly assigned to receive durvalumab alone or with a targeted therapy in the S2409 PRISM trial.
4 experts are featured in this series.
Daniel Peters, MD, aims to reduce the toxicity associated with AML treatments while also improving therapeutic outcomes.
Related Content